Joint Formulary & PAD

Gabapentin - Pain (Neuropathic)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Gabapentin
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
diabetic neuropathy, postherpetic neuralgia, PHN, neuropathic pain
Brand Names Include :
Neurontin
Important Information :
First line gabapentinoid.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Gabapentin is used to treat.

Committee Recommendations (2)

Gabapentinoids are recommended as a teatment option at step 2 of the local neuropathic pain guidelines. 
Gabapentin is preferential to pregabalin due to its lower potential for misuse.
Pregabalin may be used if gabapentin is effective but not well tolerated OR if gabapentin is ineffective.

Gabapentinoids are Controlled Drugs and a maximum supply of 30 days should be prescribed at any time.

See guidelines and other resources relating to the use of gabapentinoids below

Prescribers are reminded to undertake a proportionate risk benefit assessment prior to prescribing Pregabalin or Gabapentin for patients with a known or suspected propensity to misuse.

See Advice to Prescribers document below